The serotonin agonist, M-chlorophenylpiperazine, markedly increases levels of plasma catecholamines in the conscious rat.
Intravenous administration of the serotonin agonist, m-chlorophenylpiperazine (m-CPP), produced large, dose-dependent increases in epinephrine, norepinephrine and dopamine in plasma in normal, conscious rats. Elevations in the levels of epinephrine, norepinephrine and dopamine (10-fold, 5-fold and 2-fold, respectively) were markedly reduced in pithed and splanchnic denervated rats, suggesting that CNS mechanisms are primarily responsible for the effect of m-CPP on catecholamines in plasma. The serotonin antagonist, metergoline (0.5 mg/kg), decreased the responses of epinephrine and dopamine to m-CPP by 60-80% and also tended to decrease the response of norepinephrine. These findings are consistent with other studies reporting that stimulation of serotonergic receptors increases centrally-mediated sympathetic outflow and leads to increases in the concentrations of norepinephrine, epinephrine and dopamine in plasma.